Skip to main content

Maintain supply of knee implants, govt tells firms

Maintain supply of knee implants, govt tells firms
The government on tuesday made it manadatory for knee implant manufactures and importers to maintain production and supply of knee implants by invoking an emergency clause under the derug price control law.
The department of pharmeuticals (DoP) under the ministry of chemicals and fertilizers invoked powers under the Drugs (Prices Control) Order, 2013, to mandate firms to continue the saler iof knee implants without interruption, following the recent price capping on knee impants. DoP, in its order posted on its websitre on Tuesday, directed firms to submit a weekly report on "distributuion and "production"of knee implant systems.

The National Pharmaceutical Pricing Authority (NPPA) had in August reduced the average price for knee impant by as mych as 69%.According to notification issued by the price regulator, the most widely used complete knee implant (Cobalt Chromium) now costs Rs 54,720 plus GST, gainst Rs 1.58 lakh earlier.
NPPA also capped the price of a second surgery to Rs 1.3 lakh against Rs 2.76 lajkh earlier. Prices of Specil metals such as Titanium and Oxidised Ziorconium were also capped at Rs 76,600 (prices of these were not capped earlier: they used to cost Rs 2.49 lakh). The government has asked manufacturers to maintain production important supply of Orthopedic knee implant system that existed before august then the price caps weere announced under section 3 (i) of DPCO, 2013 The government can regulate distribution in direct any manufacturer tidays production and sale products to institution hospitals or any agency may be in case of emergency or in circumstances urgencfy or in case of non-commercial use of public interest

With the view to acheive adequate availability and regulate distribvution of drug in case of emergency or in circumstances of urgency or in caswe of non-commercuia use in public interestdirect any manufacturer of any active farmer suitable ingredient or drug or formulation to increse production into direct formulaters to serve the formulation to institutions,hospitals or any agency,"Dop said in its order .

Additionally,the companies are also directed to furnish the production figures from 2015 to 2017-2018. The move will ensure uninterrupted supply of knee implant by the manufacturers and importer.NPPA can take action against the company in case it receives any complaint of shortage or the company is charging a higher price ," said an official requesting anonymity.

The Mint, New Delhi, 27th September 2017

Comments

Popular posts from this blog

Data storage norm splits digital payments industry

Data storage norm splits digital payments industry  India’s nascent digital payment industry could be thrown into disarray due to the demand by the Reserve Bank of India (RBI) that all user data be stored within the country, fears an industry grouping, which has termed the decision as “heavy-handed”, even as others, including the country’s largest digital payment provider Paytm, have hailed the move.  In a bid to narrow the growing schism, the industry is planning to send a formal representation to the regulator highlighting its concerns, a top official told ET.  “We are trying to build a consensus on the issue," said the person adding that the representation to the central bank will be ready this week.  RBI on April 6, mandated all payment companies—global and local—to set up data storage facilities within India by October. The stringent six-month deadline has attracted the ire of several sections of the industry that fear it will lead to a disruption of wel...

Offer’s for all of you

Great Bumper Dhamaka Offer’s for all of you... It's Time to see your Business Online, WebeCreator Offer Website Designing with domain & Email @ nominal charges. For a year For More information visit us http://goo.gl/KlpppF call on 9890151261/9773197533  drop a mail to sales@webecreator.com

Sebi to finalise options in commodities today

The Commodity Derivatives Advisory Committee of the Securities and Exchange Board of India ( Sebi) will meet on Friday with senior officials of the latter, to give a final shape to the rules on options trading in commodity futures, beside revising the warehousing norms to ensure good delivery on settlement. The decision taken, after discussing with the advisory committee, will be placed before the regulator’s board, to finalise the regulations. According to knowledgeable sources, three commodities in each segment, agricultural and non- agricultural, have been proposed for introducing options. It appears commodities from the soya and guar segments are preferred in the former. From the non- agri segment, it is likely that gold, silver and crude oil will be finalised. All these These have better liquidity and both the National Commodity and Derivatives Exchange and the Multi Commodity Exchange, respectively, will be able to introduce the options. In the equity segments, options ar...